High-throughput flow cytometry for drug discovery: principles, applications, and case studies

被引：29

作者：

Ding, Mei ^{[1
]}

Kaspersson, Karin ^{[1
]}

Murray, David ^{[2
]}

Bardelle, Catherine ^{[2
]}

机构：

[1] AstraZeneca, Innovat Med & Early Dev, Discovery Sci, Pepparedsleden 1, SE-43183 Molndal, Sweden

[2] AstraZeneca, Discovery Sci, Mereside, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England

来源：

DRUG DISCOVERY TODAY | 2017年 / 22卷 / 12期

关键词：

MULTIPLEX ASSAY; IDENTIFICATION; SCREEN; INHIBITORS; ENTEROPATHY; MOLECULES; TOXICITY; PLATFORM; PROTEIN;

D O I：

10.1016/j.drudis.2017.09.005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Flow cytometry is a technology providing multiparametric analysis of single cells or other suspension particles. High-throughput (HT) flow cytometry has become an attractive screening platform for drug discovery. In this review, we highlight the recent HT flow cytometry applications, and then focus on HT flow cytometry deployment at AstraZeneca (AZ). Practical considerations for successful HT flow cytometry assay development and screening are provided based on experience from four project case studies at AZ. We provide an overview of the scientific rationale, explain why HT flow cytometry was chosen and how HT flow cytometry assays deliver new ways to support the drug discovery process.

引用

页码：1844 / 1850

页数：7

共 50 条

[41] High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery
Yang, Xiaonan
Kui, Ling
Tang, Min
Li, Dawei
Wei, Kunhua
Chen, Wei
Miao, Jianhua
Dong, Yang
FRONTIERS IN GENETICS, 2020, 11
[42] Accelerating drug discovery by high-throughput combinatorial synthesis
Banville, SC
Zuckermann, RN
PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON LABORATORY AUTOMATION AND ROBOTICS 1996, 1997, : 77 - 92
[43] High-Throughput crystallographic fragment screening for drug discovery
Metz, Alexander
Huschinann, Franziska
Schiebel, Johannes
Mueller, Utiye
Weiss, Manfred
Heine, Andreas
Melte, Gerhard
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2018, 74 : E24 - E24
[44] High-throughput kinase profiling as a platform for drug discovery
David M. Goldstein
Nathanael S. Gray
Patrick P. Zarrinkar
Nature Reviews Drug Discovery, 2008, 7 : 391 - 397
[45] High-throughput screening approaches to TB drug discovery
Stanley, Sarah A.
Grant, Sarah S.
Barczak, Amy K.
Hung, Deborah T.
TUBERCULOSIS, 2013, 93 (01) : 110 - 110
[46] Modern analytical approaches to high-throughput drug discovery
Gomez-Hens, A.
Aguilar-Caballos, M. P.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2007, 26 (03) : 171 - 182
[47] High-throughput crystallography for lead discovery in drug design
Blundell, TL
Jhoti, H
Abell, C
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) : 45 - 54
[48] High-throughput crystallization and structure determination in drug discovery
Stewart, L
Clark, R
Behnke, C
DRUG DISCOVERY TODAY, 2002, 7 (03) : 187 - 196
[49] High-throughput crystallography for lead discovery in drug design
Tom L. Blundell
Harren Jhoti
Chris Abell
Nature Reviews Drug Discovery, 2002, 1 : 45 - 54
[50] High-throughput virtual screening for drug discovery in parallel
Toledo-Sherman, LM
Chen, DQ
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (03) : 414 - 421

← 1 2 3 4 5 →